Cargando…
Molecular markers of systemic therapy response in urothelial carcinoma
Identification of reliable molecular biomarkers that can complement clinical practice represents a fascinating challenge in any cancer field. Urothelial carcinoma is a very heterogeneous disease and responses to systemic therapies, and outcomes after radical cystectomy are difficult to predict. Adva...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Second Military Medical University
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566362/ https://www.ncbi.nlm.nih.gov/pubmed/34765445 http://dx.doi.org/10.1016/j.ajur.2021.05.001 |